Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Curcumin for Adolescents with Bipolar Disorder
NCT01928043Phase 2Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Sep 2013
- Primary completion
- Mar 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in bipolar disorder (BD), sponsored by Sunnybrook Health Sciences Centre. Started Sep 2013; status: terminated.
02
Drugs
curcumin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01928043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928043.